1) Nomura S:Function and clinical significance of platelet-derived microparticles. Int J Hematol 74:397-404,2001
2) Nomura S, Tandon NN, Nakamura T, et al:High-shear-stress- induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 158:277-287,2001
3) Sims PJ, Wiedmer T, Esmon CT, et al:Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem 264:17049-17057,1989
4) Sinauridze EI, Kireev DA, Popenko NY, et al:Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97:425-434,2007
5) Yano Y, Kambayashi J, Shiba E, et al:The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J 299:303-308,1994
6) Miyazaki Y, Nomura S, Miyake T, et al:High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 88:3456-3464,1996
7) Reininger AJ, Heijnen HF, Schumann H, et al:Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 107:3537-3545,2006
8) Osumi K, Ozeki Y, Saito S, et al:Development and assessment of enzyme imunoassay for platelet-derived microparticles. Thromb Haemost 85:326-330,2001
9) Nomura S, Uehata S, Saito S, et al:Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 89:506-512,2003
10) Nomura S, Takahashi N, Inami N, et al:Probucol and ticlopidine:effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 174:329-335,2004
11) Nomura S, Inami N, Iwasaka T:Differences in functional roles between activated platelets and platelet-derived microparticles. Thromb Haemost 98:1143-1144,2007
12) Nomura S, Shouzu A, Omoto S, et al:Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121:437-443,2000
13) Nomura S, Nakamura T, Cone J, et al:Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 40:173-181,2000
14) Omoto S, Nomura S, Shouzu A, et al:Dtection of monocyte-derived microparticles in patients with typediabetes mellitus. Diabetologia 45:550-555,2002
15) Ogata N, Nomura S, Shouzu A, et al:Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 73:241-248,2006
16) Nagahama M, Nomura S, Kanazawa S, et al:Significance of anti-oxidized LDL antibody and monocyte-derived microparticles in anti-phospho-lipid antibody syndrome. Autoimmunity 36:125-131,2003
17) Matsumoto N, Nomura S, Kamihata H, et al:Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome. Thromb Haemost 91:146-154,2004
18) Nomura S, Inami N, Kimura Y, et al:Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens 21:38-44,2007
19) Nomura S, Shouzu A, Omoto S, et al:Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Thromb Res 117:385-392,2006
20) Nomura S, Shouzu A, Omoto S, et al:Activated platelet and oxidized LDL induce endothelial membrane vesiculation:clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Hemost 10:205-215,2004